Iteos Therapeutics Inc (ITOS) — Cash Flow Quality Index
Iteos Therapeutics Inc (ITOS) has a Cash Flow Quality Index of -1.33x as of December 2022. Operating cash flow of $-27.17 Million is below net income of $20.45 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore ITOS cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Iteos Therapeutics Inc Cash Flow Quality Index (2021–2022)
Historical Cash Flow Quality Index for Iteos Therapeutics Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Iteos Therapeutics Inc (ITOS) cash conversion ratio.
Annual Cash Flow Quality Index for Iteos Therapeutics Inc (2021–2022)
Year-by-year earnings quality comparison for Iteos Therapeutics Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | -1.15x | $-111.19 Million | $96.65 Million | ▼ -148.1% |
| 2021 | 2.39x | $513.14 Million | $214.52 Million | — |